In the U.S. District Court for the Eastern District of California, where a Prozac birth defects lawsuit is being heard, Judge Lawrence K. Karlton ruled to maintain the plaintiff’s accusation of Eli Lilly’s Co.’s failure to warn. Furthermore, Judge Karlton found that the plaintiff’s additional claim that Prozac’s development betrayed Eli Lilly’s codes was sufficiently established, according to HarrisMartin. As such, evidence supporting these claims will be granted presentation in the court.
Carey Danis & Lowe Prozac lawyers believe that Judge Karlton’s decision to uphold the allegation of failure to warn is important. This means that the plaintiff has the opportunity to present a Prozac lawsuit in court that establishes Eli Lilly’s disregard for patient safety and neglectful business practices.
One of the most common Prozac birth defects is persistent pulmonary hypertension of the newborn (PPHN), a condition that affects normal lung function, resulting in a lack of properly oxygenated blood. In a study published by The New England Journal of Medicine in 2006, researchers found that the risk of PPHN increased six-fold in children whose mothers used a selective serotonin re-uptake inhibitor (SSRI) antidepressant, such as Prozac, during pregnancy.
Carey Danis & Lowe is a national law firm headquartered in St. Louis whose attorneys represent victims of SSRI birth defects. Our Prozac birth defects lawyers are currently offering free legal consultations of Prozac cases, and are available to discuss your legal options. We can also assist with filing a Prozac birth defects lawsuit.
If you have concerns about the impact Prozac has on children in the womb and after birth, receive thorough answers to your questions by discussing them with one of our on-staff medical experts. Share your story with Carey Danis & Lowe today by calling 800.721.2519, or by completing a confidential personal injury claim.
